Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma
- 17 September 1993
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 218 (1), 47-58
- https://doi.org/10.1016/0009-8981(93)90221-o
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serumFEBS Letters, 1992
- Transforming growth factor beta stimulates the production of the tissue inhibitor of metalloproteinases (TIMP) by human synovial and skin fibroblastsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumorsInternational Journal of Cancer, 1990
- Tissue inhibitor of metalloproteases (TIMP) is matrix associated in aortic tissue: Report of a radioimmunoassayBiochemical and Biophysical Research Communications, 1990
- Tumor Necrosis Factor-α Induces mRNA for Collagenase and Timp in Human Skin FibroblastsConnective Tissue Research, 1990
- Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.Journal of Clinical Investigation, 1989
- High Metalloproteinase Inhibitor Content of Human Cirrhosis and Its Possible Conference of Metastasis Resistance2JNCI Journal of the National Cancer Institute, 1988
- A fibrosarcoma model derived from mouse embryo cells: Growth properties and secretion of collagenase and metalloproteinase inhibitor (TIMP) by tumour cell linesInternational Journal of Cancer, 1984
- Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosisLife Sciences, 1982
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981